UBS Group AG - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 18 filers reported holding TRANSCODE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$777
-92.9%
1,159
-70.8%
0.00%
Q1 2022$11,000
-15.4%
3,973
-24.4%
0.00%
Q4 2021$13,000
-18.8%
5,254
-1.6%
0.00%
Q3 2021$16,0005,3370.00%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders